Etiology and susceptibility of urinary tract isolates in Kosova

International Journal of Antimicrobial Agents

Volumn 23, Issue SUPPL. 1, 2004, Pages 2-5

  Raka, Lul ^a,b,c   Mulliqi Osmani, Gjyle ^a,b   Berisha, Lule ^a,b   Begolli, Lumturije ^a,b   Omeragiq, Shyhreta ^a   Parsons, Linda ^c   Salfinger, Max ^c   Jaka, Arbëresha ^a,b   Kurti, Arsim ^a,b   Jakupi, Xhevat ^a,b  

^a Department of Microbiology National Institute for Public Health of Kosova   (Serbia)

^b UNIVERSITY OF PRISHTINA   (Serbia)

^c WADSWORTH CENTER   (United States)

Author keywords

Escherichia coli; Etiology; Kosova; Urinary tract infection

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFALEXIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BACTERIURIA; CITRON; CONFERENCE PAPER; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAM POSITIVE BACTERIUM; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KLEBSIELLA; LABORATORY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTPATIENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; URINALYSIS; URINARY TRACT INFECTION; YUGOSLAVIA;

EID: 12144290938     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.009     Document Type: Conference Paper

References (19)

1. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. New England J. Med. 329:1993;1328-1334.
2. Sussman M. Urinary tract infections. In: Topley & Wilson's Microbiology and Microbial Infections. 9th ed. London: Arnold; 1998. p. 601-21.
3. Warren JW. Nosocomial urinary tract infections. In: Mandel GBJ, Dolin R, editors. Principles and Practice of Infectious Disease, vol. 5. Philadelphia: Churchill, Livingstone; 2000. p. 3028-39.
4. Clarridge JE, Johnson JR, Pezzlo MT. In: Weissfeld AS, editor. Cumitech 2B, laboratory diagnosis of urinary tract infections. American Society for Microbiology, Washington, DC, 1998.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. NCCLS document M2-A6. 6th ed. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997.
6. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM; 1999.
7. Hulley S, Cummings S, Browner W, Grady D, Hearst N, Newman Th. Designing Clinical Research. 2nd ed. Philadelphia: Lippincot Williams & Wilkins; 2001.
8. Mulliqi-Osmani G. Flora bakterore e infeksioneve urinare-ndjeshmeria e saj ndaj antibiotikeve ne korelacion me diagnozen klinike. Disertacion. Fakulteti I Mjekesise, Prishtine, 2001.
9. Gruneberg R.N. Changes in urinary pathogens and their antibiotic sensitivities 1971-1992. J. Antimicrob. Chemother. 33:1994;1-8.
10. Jones R.N., Kugler K.C., Pfaller M.A., Winokur P.L. the SENTRY Surveillance Group, North America Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagnostic Microbiol. Infect. Dis. 35:1999;55-63.
11. Hryniewicz K., Hrypa K., Szczypa K., Sulikowska A., Jankowski K., Bettejewska K.et al. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J. Antimicrob. Chemother. 47:2001;773-780.
12. Grude N., Tveten Y., Kristiansen B. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates. Clin. Microb. Infect. 7:2001;543-547.
13. Dornbusch K., King A., Legakis N. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study group on antibiotic resistance (ESGAR). Scand. J. Infect. Dis. 30:1998;281-288.
14. Gupta K.A., Scholes D., Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 281:1999;736-738.
15. Vromen M., van der Ven A.J., Knols A.M., Stobberingh E.E. Antimicrobial resistance patterns in urinary tract isolates from nursing home residents. Fifteen years of data reviewed. J. Antimicrob. Chemother. 44:1999;113-116.
16. Sahm D., Thornsbery C., Mayfield D., Jones M., Karlowsky J. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45:2001;1402-1406.
17. Zhanel G., Karlowsky J., Harding G., Carrie A., Mozzuli T., Low D. The Canadian Urinary Isolate Study Group A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxasole, ampicillin, mecillinam, nitrofurantoin and ciprofloxacin. Antimicrob. Agents Chemother. 44:2000;1089-1092.
18. Bouza E., San Juan R., Munoz P., Voss A., Kluymanths J. on behalf of Co-operative Group of European Study Group on Nosocomial Infections A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload. Clin. Microbiol. Infect. 7:2001;523-531.
19. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm A.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:1999;745-758.